Sleep disordered breathing and the impact of nocturnal non-invasive ventilatory support on quality of life in motor neurone disease

ISRCTN ISRCTN76330611
DOI https://doi.org/10.1186/ISRCTN76330611
Secondary identifying numbers RRCC804F res/1808/7002
Submission date
23/01/2004
Registration date
23/01/2004
Last edited
08/12/2008
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Nervous System Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English summary of protocol

Not provided at time of registration

Contact information

Dr Stephen Bourke
Scientific

NHS Northern & Yorkshire Regional Office
Postgraduate Institute South Tyneside
10-12 Framlington Place
Newcastle upon Tyne
NE2 4AB
United Kingdom

Phone +44 0191 284 311

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectives1. Early intervention with non-invasive ventilation will improve quality of life, survival and respiratory function in patients with motor neurone disease.
2. Domiciliary non-invasive ventilation in patients with motor neurone disease will not increase the stain experienced by the primary carer.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedNervous system diseases: motor neurone disease
Intervention1. Early intervention with non-invasive ventilation
2. Standard care
Intervention typeOther
Primary outcome measureQuality of life
1. Generic instrument: Short Form 36
2. Specific instruments: Chronic Respiratory Disease Index, Sleep Apnoea Quality of Life Index, Epworth Sleepiness Scale
Secondary outcome measures1. Survival
2. Impact on primary carer: Care Givers Strain Index
3. Hospital admissions
4. Respiratory function: Vital capacity, maximum static mouth pressures, sniff nasal inspiratory pressure
Overall study start date10/01/2000
Completion date10/01/2002

Eligibility

Participant type(s)Patient
Age groupAdult
SexNot Specified
Target number of participantsAdded December 2008: 102
Key inclusion criteriaPatients with motor neurone disease under 75 years of age and without other serious illnesses.
Key exclusion criteriaNot provided at time of registration
Date of first enrolment10/01/2000
Date of final enrolment10/01/2002

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

NHS Northern & Yorkshire Regional Office
Newcastle upon Tyne
NE2 4AB
United Kingdom

Sponsor information

NHS R&D Regional Programme Register - Department of Health (UK)
Government

The Department of Health
Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.doh.gov.uk

Funders

Funder type

Government

NHS Executive Northern and Yorkshire (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 01/02/2006 Yes No